1Anthony D. Elias,Lois J. Ayash,J. Paul Eder,Cathy Wheeler,Joan Deary,Lisa Weissman,Myla Hunt,John Critchlow,Lowell Schnipper,Emil Frei,Karen H. Antman. Escalating doses of carboplatin with high-dose ifosfamide using autologous bone marrow as support: a phase I study[J] 1991,Journal of Cancer Research and Clinical Oncology(4):S208～S213
2Gregory P. Sutton,John A. Blessing,Guy Photopulos,Michael L. Berman,Howard D. Homesley. Early phase II Gynecologic Oncology Group experience with ifosfamide/mesna in gynecologic malignancies[J] 1990,Cancer Chemotherapy and Pharmacology(1):S55～S58
3Stella M. Davies,Andrew D. J. Pearson,Alan W. Craft. Toxicity of high-dose ifosfamide in children[J] 1989,Cancer Chemotherapy and Pharmacology(1):S8～S10
4Pax H. B. Willemse,Paul E. Jong,Job B. Elema,Nanno H. Mulder. Severe renal failure following high-dose ifosfamide and mesna[J] 1989,Cancer Chemotherapy and Pharmacology(5):329～330
5C. Focan,J. Boossy,D. Focan-Henrard,M. Reginster,J. J. Claessens. Phase II trial with high-dose ifosfamide and mesna given in a 24-h infusion for advanced GI tract cancer[J] 1989,Cancer Chemotherapy and Pharmacology(3):192～193
6Martin Moncrieff,Anabell Foot. Fanconi syndrome after ifosfamide[J] 1989,Cancer Chemotherapy and Pharmacology(2):121～122
7J. Smeitink,M. Verreussel,C. Schr?der,R. Lippens. Nephrotoxicity associated with ifosfamide[J] 1988,European Journal of Pediatrics(2):164～166
8Maria A. Gieron,Larry S. Barak,Jaime Estrada. Severe encephalopathy associated with ifosfamide administration in two children with metastatic tumors[J] 1988,Journal of Neuro - Oncology(1):29～30
9T. Cerny,J. M. Margison,N. Thatcher,P. M. Wilkinson. Bioavailability of ifosfamide in patients with bronchial carcinoma[J] 1986,Cancer Chemotherapy and Pharmacology(3):261～264
10N. Brock,J. Pohl. Experimental basis of modern ifosfamide therapy[J] 1986,Journal of Cancer Research and Clinical Oncology(1):S28
